Published • loading... • Updated
Construction begins on Novartis’ RLT centre in Texas, US
Summary by Pharmaceutical-technology.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
pharmaceutical-technology.comReposted by Pharmaceutical Business review
Pharmaceutical Business reviewConstruction begins on Novartis’ RLT centre in Texas, US
Novartis has begun construction on its new 46,000ft² RLT manufacturing facility in Denton, Texas, marking the latest step in its $23bn investment in US manufacturing and research.
Novartis Texas Groundbreaking Marks Fifth US Radioligand Therapy Site in $23 Billion Expansion
Novartis has broken ground on a purpose-built 46,000 sq. ft. radioligand therapy (RLT) manufacturing facility in Denton, Texas, marking a pivotal step in the Swiss pharmaceutical giant’s $23 billion commitment to expanding its United States research and manufacturing footprint. The $280 million investment represents one of the largest capital project commitments Denton has seen in […] The post Novartis Texas Groundbreaking Marks Fifth US Radioli…
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
